Acacia Pharma Secures Series B
Acacia Pharma, a pharmaceutical company specialising in the development of drugs for supportive care, has raised 15 million pounds ($23.5 million) in a Series B financing led by Fidelity Biosciences and Novo A/S. Current investors Gilde Healthcare and Lundbeckfond Ventures also participated in the round.
3 September 2013•4 mins read
